Related Experiment Videos
[Opipramol in behavioral pharmacologic anxiety and depression models]
1Novartis Pharma AG, Basel.
Fortschritte Der Neurologie-Psychiatrie
|January 29, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand.
Pharmacopsychiatry·2004
The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Behavioural brain research·2004
Current awareness.
NMR in biomedicine·2001
[Multiple system atrophy].
Fortschritte der Neurologie-Psychiatrie·2026
[Predicting and Preventing Alzheimer's Disease].
Fortschritte der Neurologie-Psychiatrie·2026
[Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis].
Fortschritte der Neurologie-Psychiatrie·2026
Evaluating the relationship of exposure to adverse childhood experiences and pain in healthy subjects.
Fortschritte der Neurologie-Psychiatrie·2026
[Rare hereditary and acquired diseases with parkinson's syndrome].
Fortschritte der Neurologie-Psychiatrie·2026
[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].
Fortschritte der Neurologie-Psychiatrie·2026
The impact of parathyroid hormone replacement with palopegteriparatide on synthesis of 1,25-dihydroxy vitamin D in hypoparathyroidism.
Expert review of clinical pharmacology·2026
Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.
The Pan African medical journal·2026
Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.
Behavioural brain research·2026